The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStandard Chartered Regulatory News (STAN)

Share Price Information for Standard Chartered (STAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 755.00
Bid: 751.00
Ask: 751.20
Change: 0.00 (0.00%)
Spread: 0.20 (0.027%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 755.00
STAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

SCPLC announces results of PRA stress test

1 Dec 2015 07:04

RNS Number : 4778H
Standard Chartered PLC
01 December 2015
 



 

 

1 December 2015

 

Standard Chartered PLC announces results of Prudential Regulation Authority stress test

 

Standard Chartered PLC, together with its subsidiaries, (the "Group") along with other UK based financial institutions has been subject to the 2015 stress test conducted by the Prudential Regulation Authority ("PRA"). The test is designed to assess the capital adequacy of the UK banking system based on the banks' balance sheets as at 31 December 2014. The results of the stress test were announced this morning. 

The PRA did not require the Group to submit a revised capital plan.

The test applied a hypothetical stress scenario to the Group's balance sheet as at 31 December 2014 and compared the theoretical Common Equity Tier 1 capital ("CET1 Capital") ratio and Tier 1 Leverage Ratio positions of the Group before and after the impact of strategic management actions.

One of the key areas of focus in the 2015 scenario was stresses arising from an economic slowdown in Asia. Details of the PRA's approach to the stress test and the detailed results in relation to all participating banks are available from the PRA website (http://www.bankofengland.co.uk/pra/Pages/default.aspx).

Result of stress test

The Group met both the CET1 Capital ratio and the Tier 1 Leverage Ratio requirements after the impact of strategic management actions.

The results of the stress test showed that the Group had a CET1 Capital ratio of 5.1 per cent. before the impact of strategic management actions, and 5.4 per cent. after the impact of strategic management actions, compared with the threshold CET1 Capital ratio of 4.5 per cent. 

The results of the stress test also showed that the Group had a Tier 1 Leverage Ratio of 2.8 per cent. before the impact of strategic management actions, and 3.0 per cent. after the impact of strategic management actions, compared with the 3 per cent. minimum Tier 1 Leverage Ratio requirement.

Standard Chartered believes that the results demonstrate the Group's resilience to a marked slowdown across the key markets in which it operates. 

The PRA judged that in the hypothetical stress scenario the Group's Tier 1 Capital Ratio after strategic management actions reduced to 5.9 per cent. which was below the Tier 1 minimum capital requirement of 6 per cent. This assessment did not include the AT1 capital issued by the Group in April 2015.

A number of actions taken since 31 December 2014 have strengthened the Group's capital and leverage position:

• The Group reported an increase in its CET1 Capital ratio from 10.7 per cent. at the start of 2015 to 11.5 per cent. as at 30 June 20151

 

• The Group issued US$2 billion of AT1 securities in April 2015 and reported an increase in its Tier 1 Leverage Ratio from 4.5 per cent. at the start of 2015 to 5.0 per cent. as at 30 June 20152

 

• The Group announced a fully underwritten 2 for 7 rights issue in November expected to raise GB£3.3 billion (net of expenses), or approximately US$5.1 billion3

In addition, the Rights Issue (as at 30 June 2015) would have on a pro forma basis increased the Group's CET1 Capital ratio to approximately 13.1 per cent., Tier 1 Leverage Ratio to approximately 5.6 per cent. and Tier 1 Capital Ratio to approximately 14.5 per cent.

The Group is operating with capital levels above current minimum regulatory requirements and has a number of additional levers at its disposal to further manage capital. 

Group Chief Executive, Bill Winters commented: 'We are pleased to have met the PRA stress test thresholds through a significant and prolonged stress scenario. The results of the test demonstrate our resilience to a marked slowdown across the key markets in which we operate. The test was conducted on our balance sheet as at the end of 2014. Since then we have made further significant progress in strengthening our capital position. We are operating at capital levels above current minimum regulatory requirements and have a number of additional levers at our disposal to further manage capital.'

Further details

Further information on the Group's financial performance will be available on 23 February 2016 when we issue our 2015 full year results.

Notes:

1As at 30 September 2015, the Group's CET1 Capital ratio was 11.4 per cent.2As at 30 September 2015, the Group's Tier 1 Leverage Ratio was 4.8 per cent.3Based on GB£1:US$1.5429 being the exchange rate as at 2 November 2015.

For further information, please contact:

James Hopkinson, Global Head of Investor Relations +44 (0)20 7885 7151

Sarah Lindgreen, Head of Group Media Relations +44 (0)20 7885 8764

- END -

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUAUVRVRAURRA
Date   Source Headline
7th Jul 20222:10 pmRNSTotal Voting Rights
28th Jun 202212:50 pmRNSOverseas Regulatory Announcement
27th Jun 20223:00 pmRNSPublication of Final Terms
16th Jun 202211:50 amRNSPublication of a Prospectus
15th Jun 20225:00 pmRNSHolding(s) in Company
14th Jun 20221:00 pmRNSHolding(s) in Company
13th Jun 20228:00 amRNSFinancial Markets Investor Event
10th Jun 20227:30 amRNSSCPLC publishes resolvability disclosure
9th Jun 20225:35 pmRNSHolding(s) in Company
7th Jun 20225:00 pmRNSTotal Voting Rights
6th Jun 20225:10 pmRNSBlock listing Interim Review
6th Jun 20223:30 pmRNSHolding(s) in Company
31st May 20226:00 pmRNSDirector/PDMR Shareholding
25th May 202210:45 amRNSDirector Declaration
19th May 20226:19 pmRNSTransaction in Own Shares
18th May 20226:05 pmRNSTransaction in Own Shares
17th May 20226:05 pmRNSTransaction in Own Shares
16th May 20226:20 pmRNSDirector/PDMR Shareholding
16th May 20225:37 pmRNSTransaction in Own Shares
13th May 20226:00 pmRNSTransaction in Own Shares
12th May 20225:50 pmRNSTransaction in Own Shares
11th May 20226:15 pmRNSTransaction in Own Shares
10th May 20225:45 pmRNSDirector/PDMR Shareholding
10th May 20225:29 pmRNSTransaction in Own Shares
9th May 20225:45 pmRNSTransaction in Own Shares
6th May 20226:00 pmRNSTransaction in Own Shares
6th May 20225:40 pmRNSTotal Voting Rights
6th May 20229:00 amRNSDirector Declaration
5th May 20226:05 pmRNSTransaction in Own Shares
4th May 20226:25 pmRNSResult of AGM
29th Apr 20224:40 pmRNSPublication of Supplementary Prospectus
29th Apr 20221:15 pmRNSDirectorate Change
28th Apr 20226:00 pmRNSTransaction in Own Shares
28th Apr 20224:10 pmRNS1Q 2022 Pillar 3 Disclosures
28th Apr 20227:00 amRNSFirst Quarter 2022 Results
27th Apr 20225:55 pmRNSTransaction in Own Shares
26th Apr 20226:10 pmRNSTransaction in Own Shares
26th Apr 20223:50 pmRNSGroup Company Secretary Change
25th Apr 20225:50 pmRNSTransaction in Own Shares
22nd Apr 20225:40 pmRNSTransaction in Own Shares
21st Apr 20225:57 pmRNSTransaction in Own Shares
20th Apr 20225:35 pmRNSTransaction in Own Shares
19th Apr 20226:15 pmRNSTransaction in Own Shares
14th Apr 20226:10 pmRNSTransaction in Own Shares
14th Apr 202210:00 amRNSChanges to refocus, simplify AME region presence
13th Apr 20226:05 pmRNSTransaction in Own Shares
13th Apr 20229:30 amRNSRe-presentation of financials in new structure
12th Apr 20225:50 pmRNSTransaction in Own Shares
11th Apr 20225:30 pmRNSTransaction in Own Shares
8th Apr 20226:15 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.